Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence, Awareness, Treatment and Control of Hypertension in Four Middle East Countries Publisher Pubmed



Yusufali AM1 ; Khatib R2 ; Islam S3 ; Alhabib KF4 ; Bahonar A5 ; Swidan HM6 ; Khammash U7 ; Alshamiri MQ4 ; Rangarajan S3 ; Yusuf S3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hatta Hospital, Dubai Health Authority, Box 4545, Dubai, United Arab Emirates
  2. 2. Department of Public Health Sciences, Loyola Medical Center, Maywood, IL, United States
  3. 3. Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada
  4. 4. Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia
  5. 5. Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Primary Healthcare, Dubai Health Authority, Dubai, United Arab Emirates
  7. 7. United Nations Relief and Works Agency for Palestine Refugees in the Near East, Jerusalem, Palestine

Source: Journal of Hypertension Published:2017


Abstract

Objective: We report the prevalence, awareness, treatment, and control of hypertension across four Middle Eastern countries (Iran, Occupied Palestinian Territory, Saudi Arabia, and United Arab Emirates), using a standardized and uniform method. Methods: The Prospective Urban Rural Epidemiology study enrolled participants from 52 urban and 35 rural communities from four countries in the Middle East. We report results using definitions of hypertension, prevalence, awareness, treatment, and control, and the standards for uniform reporting of hypertension in adults as recently recommended by the World Hypertension League expert committee. Results: Data for analyses were available on 10 516 participants, of whom 5082 (48%) were men. The mean age was 49 (±9.4) years for men and 48 (±9.3) years among women. A total of 3270 participants had hypertension (age-standardized rates, 33%), and n = 1807 (49%) of these participants were aware of their diagnosis. Of those with hypertension, n = 1754, (47%) were treated and only n = 673, (19%) had controlled blood pressure levels. Only 17% (n = 541) of those treated for hypertension received two or more blood pressure-lowering medications and 15% (n = 499) received statins. The prevalence, awareness, treatment, and control of blood pressure were higher among women and older (50-69 years) participants compared with men and younger individuals (30-49 years) (P < 0.0001 for all). The prevalence was higher in rural communities; however, awareness, treatment, and control were significantly higher among urban dwellers. Conclusion: Findings from this study indicate the need for improvements in hypertension diagnosis and treatment in the Middle East, especially in rural communities, men and younger individuals. © 2017 Wolters Kluwer Health, Inc. All rights reserved.
Related Docs
View other Related Docs
1. Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries, JAMA (2013)
2. Incident Hypertension and Its Predictors: The Isfahan Cohort Study, Journal of Hypertension (2014)
3. Knowledge, Treatment, Control, and Risk Factors for Hypertension Among Adults in Southern Iran, International Journal of Hypertension (2015)
4. Wealth and Cardiovascular Health: A Cross-Sectional Study of Wealth-Related Inequalities in the Awareness, Treatment and Control of Hypertension in High-, Middle- and Low-Income Countries, International Journal for Equity in Health (2016)
5. The Impact of a 6-Year Comprehensive Community Trial on the Awareness, Treatment and Control Rates of Hypertension in Iran: Experiences From the Isfahan Healthy Heart Program, BMC Cardiovascular Disorders (2010)
6. Prevalence, Awareness, Treatment, Control, and Risk Factors of Hypertension Among Adults: A Cross-Sectional Study in Iran, Epidemiology and Health (2018)
7. Availability and Affordability of Blood Pressure-Lowering Medicines and the Effect on Blood Pressure Control in High-Income, Middle-Income, and Low-Income Countries: An Analysis of the Pure Study Data, The Lancet Public Health (2017)
8. Does Greater Individual Social Capital Improve the Management of Hypertension? Cross-National Analysis of 61 229 Individuals in 21 Countries, BMJ Global Health (2017)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (58)
Roya Kelishadi (51)
Other Related Docs
9. Design and Implementation of a Combined Observational and Interventional Study: Trends of Prevalence, Awareness, Treatment and Control Hypertension and the Effect of Expanded Chronic Care Model on Control, Treatment and Self-Care, ARYA Atherosclerosis (2017)
10. The Household Economic Burden of Non-Communicable Diseases in 18 Countries, BMJ Global Health (2020)
11. Comparison of Multiple Blood Pressure Frequency Methods With Optimum Blood Pressure Measurement Among Iranian Individuals, Journal of Research in Medical Sciences (2020)
12. Prevalence, Awareness, Treatment, and Control of Hypertension in an Isfahan State Institution Sample, Journal of Tehran University Heart Center (2018)
13. Lifestyle Interventions for Hypertension Treatment Among Iranian Women in Primary Health-Care Settings: Results of a Randomized Controlled Trial, Journal of Research in Medical Sciences (2015)
14. Prevalence of Hypertension in Iran 1980-2012: A Systematic Review, Journal of Tehran University Heart Center (2016)
15. The Impact of Educational Intervention on Self-Care Behaviors in Overweight Hypertensive Women: A Randomized Control Trial, ARYA Atherosclerosis (2017)
16. Prevalence of Pre-Hypertension and Hypertension, Awareness, Treatment, and Control of Hypertension, and Cardiovascular Risk Factors in Postmenopausal Women, ARYA Atherosclerosis (2021)
17. Urinary Sodium Excretion, Blood Pressure, Cardiovascular Disease, and Mortality: A Community-Level Prospective Epidemiological Cohort Study, The Lancet (2018)
18. Prevalence of High Blood Pressure in Iranian Adults Based on the 2017 Acc/Aha Guideline, Medical Journal of the Islamic Republic of Iran (2019)
19. Blood Pressure Pattern in Urban and Rural Areas in Isfahan, Iran, Journal of Human Hypertension (1997)
20. Standards for the Uniform Reporting of Hypertension in Adults Using Population Survey Data: Recommendations From the World Hypertension League Expert Committee, Journal of Clinical Hypertension (2014)
21. Nationwide Survey of Prevalence and Risk Factors of Prehypertension and Hypertension in Iranian Adults, Journal of Hypertension (2008)
22. The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results, Journal of Diabetes and Metabolic Disorders (2023)
23. Use of Cardiovascular Disease Secondary Prevention Medications in Four Middle East Countries in a Community Setting, Global Heart (2024)
24. Prevalence of Hypertension and Associated Risk Factors in Isfahan, Islamic Republic of Iran, Eastern Mediterranean Health Journal (1999)
25. Metabolic, Behavioural, and Psychosocial Risk Factors and Cardiovascular Disease in Women Compared With Men in 21 High-Income, Middle-Income, and Low-Income Countries: An Analysis of the Pure Study, The Lancet (2022)
26. Update of the Clinical Guideline for Hypertension Diagnosis and Treatment in Iran, Clinical Hypertension (2024)
27. Factors Affecting Uncontrolled Hypertension in an Iranian Population, Iranian Heart Journal (2013)
28. Determinants of Awareness, Treatment and Control of Hypertension in Isfahan, Central Iran, Archives of Medical Science (2009)
29. Evaluating Factors Associated With Uncontrolled Hypertension: Isfahan Cohort Study, Iran, ARYA Atherosclerosis (2014)
30. Variations in Common Diseases, Hospital Admissions, and Deaths in Middle-Aged Adults in 21 Countries From Five Continents (Pure): A Prospective Cohort Study, The Lancet (2020)
31. Variations Between Women and Men in Risk Factors, Treatments, Cardiovascular Disease Incidence, and Death in 27 High-Income, Middle-Income, and Low-Income Countries (Pure): A Prospective Cohort Study, The Lancet (2020)
32. Long-Term Exposure to Outdoor and Household Air Pollution and Blood Pressure in the Prospective Urban and Rural Epidemiological (Pure) Study, Environmental Pollution (2020)
33. Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-Income, Middle-Income, and Low-Income Countries: An Analysis of the Pure Study Data, The Lancet (2016)
34. The Iranian National Blood Pressure Measurement Campaign: What Do the Process and Output Evaluation Say?, Archives of Iranian Medicine (2022)
35. Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries, New England Journal of Medicine (2014)
36. Worldwide Trends in Blood Pressure From 1975 to 2015: A Pooled Analysis of 1479 Population-Based Measurement Studies With 19·1 Million Participants, The Lancet (2017)
37. Associations of Outdoor Fine Particulate Air Pollution and Cardiovascular Disease in 157 436 Individuals From 21 High-Income, Middle-Income, and Low-Income Countries (Pure): A Prospective Cohort Study, The Lancet Planetary Health (2020)
38. Total Cardiovascular Risk Approach to Improve Efficiency of Cardiovascular Prevention in Resource Constrain Settings, Journal of Clinical Epidemiology (2011)
39. Modifiable Risk Factors, Cardiovascular Disease, and Mortality in 155 722 Individuals From 21 High-Income, Middle-Income, and Low-Income Countries (Pure): A Prospective Cohort Study, The Lancet (2020)
40. Maternal or Paternal History: Which One Plays More Important Role in Developing Hypertension?, ARYA Atherosclerosis (2022)
41. The Impact of Obesity on Hypertension and Diabetes Control Following Healthy Lifestyle Intervention Program in a Developing Country Setting, Journal of Research in Medical Sciences (2011)
42. Determinants of Uncontrolled Hypertension in an Iranian Population, ARYA Atherosclerosis (2014)
43. Worldwide Trends in Hypertension Prevalence and Progress in Treatment and Control From 1990 to 2019: A Pooled Analysis of 1201 Population-Representative Studies With 104 Million Participants, The Lancet (2021)
44. Perceived Built Environment Characteristics Associated With Walking and Cycling Across 355 Communities in 21 Countries, Cities (2023)
45. The Effect of Educational Intervention on Self-Care Behavior in Hypertensive Older People: Applying the Health Belief Model, Journal of Education and Health Promotion (2022)
46. Association of Sitting Time With Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries, JAMA Cardiology (2022)
47. Hypertension in Type 2 Diabetes Mellitus in Isfahan, Iran: Incidence and Risk Factors, Diabetes Research and Clinical Practice (2005)
48. Hypertension Control in Industrial Employees: Findings From Shimsco Study, ARYA Atherosclerosis (2012)
49. Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries, JAMA Internal Medicine (2021)
50. Associations of Urinary Sodium Excretion With Cardiovascular Events in Individuals With and Without Hypertension: A Pooled Analysis of Data From Four Studies, The Lancet (2016)